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Endobronchial involvement of extrapulmonary malignant tumors is uncommon and mostly associated with breast, kidney, colon,
and rectum carcinomas. A 68-year-old male with a prior diagnosis of colon non-Hodgkin lymphoma (NHL) was admitted to the
hospital with a complaint of cough, sputum, and dyspnea. The chest radiograph showed right hilar enlargement and opacity at
the right middle zone suggestive of a mass lesion. Computed tomography of thorax revealed a right-sided mass lesion extending
to thoracic wall with the destruction of the third and the fourth ribs and a right hilar mass lesion. Fiberoptic bronchoscopy was
performed in order to evaluate endobronchial involvement and showed stenosis with mucosal tumor infiltration in right upper
lobe bronchus. The pathological examination of bronchoscopic biopsy specimen reported diffuse large B-cell lymphoma and
the patient was accepted as the endobronchial recurrence of sigmoid colon NHL. The patient is still under treatment of R-ICE
(rituximab-ifosfamide-carboplatin-etoposide) chemotherapy and partial regression of pulmonary lesions was noted after 3 courses
of treatment.
1. Introduction
Endobronchial involvement of extrapulmonary malignant
tumors is uncommon andmostly associated with breast, kid-
ney, colon, and rectum carcinomas [1, 2]. Although the lung
is a frequent site for lymphoma involvement, endobronchial
metastasis of non-Hodgkin lymphoma (NHL) is extremely
rare.
Extranodal lymphomas originating in solid organs
account for one-third of all cases of NHL. Gastrointestinal
(GI) tract is themost common site of extranodal lymphomas.
GI tract lymphomas occur most commonly in the stomach
and colorectal NHL accounts for only 10–20% of them [3].
NHL originates from B or T lymphocytes. Mucosa-
associated lymphoid tissue (MALT) and diffuse large B-
cell lymphoma (DLBCL) are the most commonly observed
histological subtypes in the GI tract [4]. DLBCL of the GI is
an aggressive lymphomawhichmore commonly affectsmales
with a median age of 50–60 years [5]. The reported 5-year
survival is relatively poor, ranging between 27 and 55%.
Here, we present a patient with endobronchial involve-
ment of diffuse large B-cell lymphoma who has completely
remitted sigmoid colon NHL as a primary site.
2. Case Report
A 68-year-old male was admitted to the hospital with a
complaint of diarrhea, abdominal pain, weight loss, and
hematochezia. Ulcerated plaque-like lesionswith local necro-
tizing areas along the 10 cm segment of sigmoid colon
were detected in colonoscopy. The pathological examination
of biopsy material was suggestive of malignancy and left
hemicolectomy was performed. The patient was diagnosed
as stage II diffuse large B-cell lymphoma based on surgical
biopsy and radiological findings. The patient was treated
with 8 courses of R-CHOP (rituximab, cyclophosphamide,
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Figure 1: Subcarinal and right hilar lymphadenopathies in thorax
CT.
Figure 2: Stenosis with mucosal tumor infiltration in right upper
lobe bronchus.
doxorubicin, vincristine, and prednisolone) chemotherapy
followed by pelvic-paraaortic radiotherapy (RT). Complete
remission was achieved with the treatment with no signs of
recurrence in the following radiological examinations.
Patient was readmitted with the symptoms of cough,
sputum, and dyspnea three months after the treatment
completion. He was good in clinical condition, his heart
rate was 92/min, respiratory rate was 26/min, blood pressure
was 130/80mmHg, and temperature was 38.2∘C on phys-
ical examination. Chest examination indicated decreased
breath sounds over the middle zone of right hemithorax.
The chest radiograph showed right hilar enlargement and
opacity at the right middle zone suggestive of a mass
lesion. Computed tomography of thorax revealed a right-
sided mass lesion extending to thoracic wall with the
destruction of the third and the fourth ribs and a right
hilar mass lesion obstructing the right upper lobe and
intermediate bronchus with a postobstructive consolidation.
There were subcarinal and right hilar lymphadenopathies
accompanied with parenchymal findings (Figure 1). Fiberop-
tic bronchoscopy (FOB) was performed in order to evalu-
ate endobronchial involvement and stenosis with mucosal
tumor infiltration in right upper lobe bronchus was detected
(Figure 2). The pathological examination of bronchoscopic
Figure 3: The figure demonstrates section belonging to bronchial
mucosa.There is diffuse infiltration of atypical lymphoid cells under
regular bronchial epithelium.
biopsy specimen was reported as diffuse large B-cell lym-
phoma and the patient was accepted as the endobronchial
recurrence of sigmoid colon NHL (Figure 3). The patient
is still under treatment of R-ICE (rituximab-ifosfamide-
carboplatin-etoposide) chemotherapy and partial regression
of pulmonary lesions was noted after 3 courses of treatment.
3. Discussion
We presented an endobronchial diffuse large B-cell lym-
phoma in a patient with colon DLBCL in which complete
remission was achieved and no recurrence was noted during
three months of followup.
DLBCL is an aggressive form of non-Hodgkin lymphoma
and comprises approximately 30% of all lymphomas. It
usually occurs in lymph nodes while extranodal presentation
most commonly involves the gastrointestinal tract, bone
marrow, and skin [6].
Primary pulmonary lymphomausually presents asMALT
lymphoma while lung DLBCL is reported only in case
reports. The most frequently reported pulmonary involve-
ment is a lungmass usually greater than 5 cm in diameter [7].
Pleural involvement presents as an important extranodal site
for DLBCL, which is also found to be associated with overall
survival [8].
In a series consisting of 82 patients with median age of 61
years, Neri et al. found that themost frequent symptomswere
cough and chest pain and no B symptoms were present in
primary lung DLBCL patients. They have reported complete
remission in 94% of the patients, reported overall survival
rate of 92%, and suggested that primary lung DLBCL is a
disease with good prognosis [7].
On the other hand, extranodal involvement is consid-
ered as a poor prognostic factor in patients with DLBCL.
Takahashi et al. reported a retrospective study evaluating the
prognostic impact of each extranodal site in 1221 patientswith
extranodal DLBCL. Lung involvement was found in 3.7%
of the patients and additional pleural involvement was also
reported in 5.2% of them [8]. Although characteristics of
lung involvement are not mentioned in this paper, previous
reports suggested that endobronchial lesions are extremely
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rare in DLBLC and they are generally associated with
enlarged mediastinal lymph nodes and bilateral infiltration
of lung parenchyma and/or mass lesion [9]. Endobronchial
lymphoma is classified into two types, according to pattern
of involvement. Type I includes diffuse submucosal infiltrates
originating from hematogenous or lymphangitic spread in
the presence of systemic lymphoma. Type II (similar to our
patient) includes airway involvement by a localized mass
due to direct spread of lymphoma from adjacent lymph
nodes or arising de novo frombronchus-associated lymphoid
tissue (BALT). Type II lesions have been associated in all
instances with signs of airway obstruction such as cough or
wheezes [10]. Furthermore, the majority of the cases with
extranodal DLBCL were presented as solitary extranodal
site and multiple extranodal involvements were reported
in about 20% of the cases. Recent case report from Sakai
et al. suggested that multiple extranodal DLBCL might be
associated with chromosome translocations [11].
In conclusion, endobronchial DLBCL accompanied by
colon lymphoma is extremely rare in previous reports.
Localized endobronchial lesion resembling primary lung
carcinoma might be observed in lymphoma especially in
cases with underlying extranodal NHL and bronchoscopic
evaluation is essential in order to make the differential
diagnosis.
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